StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) stock

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3031% above fair value
$414.12−3.68 (-0.88%)

Close on Nov 17, 2026Market cap $28.85BP/E 46.5Yield 0.21%

West Pharmaceutical Services operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

West Pharmaceutical Services's operating cash flow for the twelve months ending Sep 30, 2026 was $654.50M, down 5.7% year over year. For fiscal 2025 it was $754.80M, up 15.5% from the year before. Over ten years it grew 13.5% a year on average. The highest annual figure on record is $776.50M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$754.80M+15.5%
FY2024Dec 31, 2024$653.40M-15.9%
FY2023Dec 31, 2023$776.50M+7.3%
FY2022Dec 31, 2022$724.00M+24.0%
FY2021Dec 31, 2021$584.00M+23.6%
FY2020Dec 31, 2020$472.50M+28.7%
FY2019Dec 31, 2019$367.20M+27.2%
FY2018Dec 31, 2018$288.60M+9.6%
FY2017Dec 31, 2017$263.30M+20.0%
FY2016Dec 31, 2016$219.40M+3.3%
FY2015Dec 31, 2015$212.40M+16.1%
FY2014Dec 31, 2014$182.90M-17.1%
FY2013Dec 31, 2013$220.50M+17.7%
FY2012Dec 31, 2012$187.40M+43.4%
FY2011Dec 31, 2011$130.70M-5.5%
FY2010Dec 31, 2010$138.30M+0.4%
FY2009Dec 31, 2009$137.70M+2.0%
FY2008Dec 31, 2008$135.00M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$189.50M-3.9%
Q2 FY2026Jun 30, 2026$124.00M-30.0%
Q1 FY2026Mar 31, 2026$89.90M-30.5%
Q4 FY2025Dec 31, 2025$251.10M+32.1%
Q3 FY2025Sep 30, 2025$197.20M+9.5%
Q2 FY2025Jun 30, 2025$177.10M+7.3%
Q1 FY2025Mar 31, 2025$129.40M+9.5%
Q4 FY2024Dec 31, 2024$190.10M-20.5%
Q3 FY2024Sep 30, 2024$180.10M-21.7%
Q2 FY2024Jun 30, 2024$165.00M-2.5%
Q1 FY2024Mar 31, 2024$118.20M-14.4%
Q4 FY2023Dec 31, 2023$239.10M+3.6%
Q3 FY2023Sep 30, 2023$230.10M+36.2%
Q2 FY2023Jun 30, 2023$169.20M-2.3%
Q1 FY2023Mar 31, 2023$138.10M-8.7%
Q4 FY2022Dec 31, 2022$230.80M+43.5%
Q3 FY2022Sep 30, 2022$168.90M-11.2%
Q2 FY2022Jun 30, 2022$173.10M+19.9%
Q1 FY2022Mar 31, 2022$151.20M+70.5%
Q4 FY2021Dec 31, 2021$160.80M+8.1%
Q3 FY2021Sep 30, 2021$190.10M+60.3%
Q2 FY2021Jun 30, 2021$144.40M-2.5%
Q1 FY2021Mar 31, 2021$88.70M+55.3%
Q4 FY2020Dec 31, 2020$148.70M+39.8%
Q3 FY2020Sep 30, 2020$118.60M+9.7%
Q2 FY2020Jun 30, 2020$148.10M+40.9%
Q1 FY2020Mar 31, 2020$57.10M+20.0%
Q4 FY2019Dec 31, 2019$106.40M+45.4%
Q3 FY2019Sep 30, 2019$108.10M+22.3%
Q2 FY2019Jun 30, 2019$105.10M+28.2%
Q1 FY2019Mar 31, 2019$47.60M+5.8%
Q4 FY2018Dec 31, 2018$73.20M-10.2%
Q3 FY2018Sep 30, 2018$88.40M+16.6%
Q2 FY2018Jun 30, 2018$82.00M-3.9%
Q1 FY2018Mar 31, 2018$45.00M+117.4%
Q4 FY2017Dec 31, 2017$81.50M+13.5%
Q3 FY2017Sep 30, 2017$75.80M–
Q2 FY2017Jun 30, 2017$85.30M–
Q1 FY2017Mar 31, 2017$20.70M–
Q4 FY2016Dec 31, 2016$71.80M–

More West Pharmaceutical Services figures

See a number that looks wrong?